Ticket Price
Free
Licensing Executives Society (LES USA & Canada)
View AgencyWhat is LES International? The Licensing Executives Society International (LESI) has a clear and distinguishable focus on the business aspects of IP from a global perspective with a broad variety of experts from all fronts and sectors dealing with IP transactions, IP valuation and monetization, innovation protection, IP commercialization, IP management, IP licensing and litigation. LESI is an IP thought leader think tank, a non-profit society being strictly non-political and free to grow through the creation of member societies throughout the world irrespective of politics or the state of technology development. LESI offers world leading events (virtual and life), useful resources and publications for deal-making / education / best practices and customized committees based on a network of leaders in their field.
Message OrganiserIntelligent Dealmaking: Key Licensing Strategies for AI-Driven Biopharma
Tuesday, May 19, 2026
Webinar
Event Overview
Artificial intelligence (AI) is rapidly playing a pivotal role in transforming the biopharmaceutical landscape, including its influence on every stage from drug discovery to development and commercialization. As the USPTO shifts patent policy to keep pace with this explosive growth, licensing deals have likewise become increasingly dynamic to account for the new challenges that AI poses in the areas of data sharing, confidentiality, inventorship, patentability, IP ownership, and other areas.
In this webinar, LES USA-Canada's Life Sciences Sector will delve into this complex situation and provide an analytical framework to help companies analyze how to effectively leverage AI in several exemplary deal scenarios.
